Integrative Metabolomic and Genetic Analyses Implicate Sphingomyelin in Primary Open-Angle Glaucoma Through Intraocular Pressure
Ophthalmology Science · 2026-11 · 101459
DOI: 10.1016/j.xops.2026.101459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Science, 2026-11. Verfasst von Hengtong Li und 12 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Medical Research Council.
Abstract (Originalsprache)
Purpose
To identify circulating metabolites associated with primary open-angle glaucoma (POAG) and to determine whether genetically supported metabolic signals are linked to intraocular pressure (IOP), the principal modifiable risk factor for glaucoma.
Design
Prospective cohort study with integrated genetic causal inference analyses.
Participants
Observational analyses included 252226 European participants from the UK Biobank and 8683 Asian participants from the multi-ethnic Singapore Epidemiology of Eye Diseases study. Genetic analyses used European genome-wide association study summary statistics for 233 circulating metabolites and POAG (16677 cases and 199580 controls).
Methods
Metabolites were prioritized using prospective cohort analyses, genetic correlation, two-sample Mendelian randomization, and latent causal variable analysis. Multivariable Mendelian randomization was used to estimate independent effects. Associations with glaucoma-related endophenotypes, mediation through IOP, colocalization, and drug-target relevance were subsequently evaluated. Main Outcome Measures POAG risk and IOP.
Results
In the final multivariable Mendelian randomization analysis, higher genetically predicted sphingomyelin levels were associated with increased POAG risk after accounting for the other metabolites included in the model (odds ratio, 1.58 per SD increase; 95% confidence interval [CI]: 1.04–2.40; P = 0.03). Higher sphingomyelin levels were also associated with higher IOP in the UK Biobank (β = 2.20 mmHg per mmol/L; 95% CI: 1.79–2.61; P = 1.77×10 -25 ) and SEED (β = 2.56 mmHg per mmol/L; 95% CI, 1.71–3.40; P = 3.21×10 -9 ). Mediation analyses supported a partial indirect effect through IOP (β = 0.049; 95% CI: 0.007–0.091; P = 0.023). Colocalization suggested a shared signal at ATXN2 , and drug-target Mendelian randomization prioritized three sphingomyelin pathway-related proteins.
Conclusions
Sphingomyelin was associated with higher IOP and increased POAG risk, with genetic evidence supporting partial mediation through IOP. These findings link sphingomyelin-related biology to the central modifiable pathway in glaucoma and support further mechanistic investigation.
Förderung
- National Medical Research Council
Zitieren
APA
Li, H., Xue, C. C., Wang, S., Fan, Q., Yu, M., Cao, J., Chee, M. L., Zhang, X., Nusinovici, S., Xu, T., Liu, D., Chong, R. S., & Cheng, C. (2026). Integrative Metabolomic and Genetic Analyses Implicate Sphingomyelin in Primary Open-Angle Glaucoma Through Intraocular Pressure. Ophthalmology Science, 101459. https://doi.org/10.1016/j.xops.2026.101459
Vancouver
Li H, Xue CC, Wang S, Fan Q, Yu M, Cao J, et al. Integrative Metabolomic and Genetic Analyses Implicate Sphingomyelin in Primary Open-Angle Glaucoma Through Intraocular Pressure. Ophthalmology Science. 2026:101459. doi:10.1016/j.xops.2026.101459
BibTeX
@article{Li2026,
author = {Li, Hengtong and Xue, Can Can and Wang, Sushan and Fan, Qiao and Yu, Marco and Cao, Jiahui and Chee, Miao Li and Zhang, Xiayin and Nusinovici, Simon and Xu, Ting and Liu, Dianbo and Chong, Rachel S. and Cheng, Ching-Yu},
title = {Integrative Metabolomic and Genetic Analyses Implicate Sphingomyelin in Primary Open-Angle Glaucoma Through Intraocular Pressure},
journal = {Ophthalmology Science},
year = {2026},
pages = {101459},
doi = {10.1016/j.xops.2026.101459}
}
EUVIMED